Evidence map›Paper›PMID 38404440›Full record

ArticleMissouri medicine

Human Platelet Derived Mitochondrial OPA-1 Isoforms and Interaction With TDP-43 in Neurodegenerative Diseases.

Su Han Lee, Duyen Pham, Edina Kosa, Abdulbaki Agbas

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Su Han LeeCollege of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.
Duyen PhamCollege of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.
Edina KosaCollege of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.
Abdulbaki AgbasCollege of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.
Kansas City University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optic atrophy 1(OPA1) is a GTPase protein that controls mitochondrial fusion, cristae integrity, and mtDNA maintenance. In neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), the mitochondrial network morphology is compromised. Studies on TAR-DNA binding protein 43 (TDP-43) has been the focus in our lab. OPA1 and TDP-43 interaction may shed a light on how aberrant TDP-43 interacts with OPA1, which will lead to mitochondrial dysfunction. The preliminary study tested the idea of whether OPA1 and TDP-43 are physically interacting in human platelet derived mitochondria obtained from healthy human subjects.

Indexed as

Amyotrophic Lateral SclerosisDNA-Binding ProteinsGTP PhosphohydrolasesNeurodegenerative DiseasesDNA, MitochondrialHumansMitochondriaProtein IsoformsDNA-Binding ProteinsDNA, MitochondrialGTP PhosphohydrolasesOPA1 protein, humanProtein IsoformsTARDBP protein, human

Identifiers

PMID38404440
PMCPMC10887457
OpenAlexW4394738323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.